We will exhibit at the DDS Society academic conference.

Accelerating formulation optimization for vaccine and pharmaceutical development.

To create the optimal LNP, it takes a tremendous amount of time and effort to examine and pursue formulation conditions. LNPs are nanoparticles composed of multiple lipids. Therefore, it is necessary to find the optimal conditions such as the mixing ratios, the ratio of lipids to payload, and the flow rates during mixing. Furthermore, we must also consider throughput issues. Sunscreen can produce up to 96 types of small LNPs within six hours, thus solving the previous throughput problems. This means that it is possible to explore a greater number of formulation condition investigations in a single day. • Fully automated execution of up to 96 types of condition investigations within six hours • 200 μL to 2 mL per experiment • Flow rate of 0.1 to 30 mL/min • Reusable microfluidic chips • Seamless scale-up through process and protocol optimization

• Other Physics and Chemistry Equipment

Efficient mass production of LNPs - Supporting everything from small-scale condition testing to scale-up.

Once we succeed in finding the optimal formulation conditions for sunscreen, let's use Sunshine to adjust the size of the LNP. Furthermore, we will optimize the protocols and processes for scaling up. We will find the ideal flow rate and explore different mixing options. Next, we will adjust these to the appropriate dilution factor that can keep them stable. Once everything is in place, Sunshine will transition to continuous mode, allowing us to produce several dozen liters in a day. In other words, we will achieve process development and scaling up on a single platform. Many researchers have likely been looking forward to the birth of such a groundbreaking system. • 10 experiments in 15 minutes • Fraction & total flow • From 1 mL to continuous flow • Flow rate 0.1 to 30 mL/min • Reusable microfluidic chips • Possible transition of protocols from sunscreen

• Other Physics and Chemistry Equipment

Accelerating formulation optimization for vaccine and pharmaceutical development.

The transition from LNP to GMP is a costly and complicated process. Typically, this requires switching equipment, using different flow paths and mixing devices, and essentially re-developing and re-validating everything that has been painstakingly done so far. With Sunbather, the transition to GMP can be done easily thanks to its recording features, interchangeable flow paths, and easily transferable design. Sunbather uses the same mixing process and protocols as the Sunscreen and Sunshine from the same Sun series, allowing for easy transition of adjusted formulation conditions to GMP. - Up to 1.8 L/h - Integrated inline dilution - Fully interchangeable flow paths - A wide variety of mixing devices - Software compliant with 21 CFR Part 11 - Process transferable from Sunshine

• Other Physics and Chemistry Equipment

Quality assessment of proteins, nucleic acids, AAV, LNP, etc. is possible with trace amounts and high throughput.

"Stunner" is a product that allows simultaneous acquisition of UV/Vis concentration, dynamic light scattering (DLS), and static light scattering (SLS) data from a 2μL identical sample. It enables detailed investigation of AAV and adenoviruses to measure total capsid titer and Empty/Full ratios, as well as to obtain payload concentration and size data of lipid nanoparticles all at once. You can analyze concentration, hydrodynamic size, polydispersity, and the presence of aggregates collectively, allowing you to assess the quality of proteins. This way, you can immediately determine whether your AAV, adenoviruses, lipid nanoparticles, or proteins are suitable for your purposes. [Features] ■ Measure up to 96 samples in a batch in 60 minutes*/12 minutes** *When measured by DLS **When measured by UV/Vis only [Applications] ■ AAV/Adenovirus capsid titer ■ AAV/Adenovirus Empty/Full ratio ■ Lipid nanoparticle (LNP) payload amount ■ Aggregate measurement ■ Concentration measurement ■ Sizing & polydispersity ■ B22 & kD *For more details, please refer to the PDF document or feel free to contact us.

• Other protein analysis

Up to 8 samples can be processed simultaneously! Automatic and hassle-free buffer exchange and concentration that used to be complicated!

Buffer exchange and concentration must be performed as a sample preprocessing step. This is a labor-intensive task that takes a long time, requiring your presence throughout the process. "UNAGI" is a fully hands-free benchtop buffer exchange solution designed to take over this tedious task. It can process up to 8 samples simultaneously. The software is very easy to operate, allowing you to be anywhere during the work, eliminating the need to stay in the laboratory the entire time. 【Features】 ■ Simultaneous processing of up to 8 samples ■ Efficient solvent removal prevents sample adsorption, achieving over 96% recovery rate ■ Built-in recipes for UF/DF buffer exchange ■ User-friendly software ■ Concentrates up to 8 diluted samples from 48mL to 8mL in one go *For more details, please refer to the PDF document or feel free to contact us.

• Other Protein Research Software
• DNA analysis

[Video Available] Are you spending a lot of time and effort on buffer exchange and concentration work? You can streamline the sample preprocessing steps with this device.

Buffer exchange and concentration must be performed as a pre-treatment of the sample, which is a time-consuming task. This process takes a long time, and you have to be present the entire time. "UNAGI" is a fully hands-free benchtop buffer exchange solution designed to perform this tedious task for you. You can be anywhere during the process, eliminating the need to stay in the laboratory the whole time. 【Features】 ■ Simultaneous processing of up to 8 samples ■ Efficient solvent removal to prevent sample adsorption, achieving over 96% recovery rate ■ Built-in recipes for UF/DF buffer exchange ■ User-friendly software ■ Concentration of up to 8 diluted samples from 48mL to 8mL in one go *For more details, please refer to the PDF document or feel free to contact us.

• Other Protein Research Software
• Other filtration and separation equipment

Introducing the details of the newly launched LNP production and screening device.

Researchers of lipid nanoparticles (LNPs) spend a tremendous amount of time on screening, optimization, and scaling up experiments to achieve optimal performance, spot-on targeting, and controlled release of active pharmaceutical ingredients (APIs). Factors such as solubility, pH stability, payload release, and encapsulation all depend on particle size, shape, and structure. In other words, to obtain the right formulation, it is necessary to explore a vast number of formulation parameters and process parameters one by one, and even if a perfect formulation is found, scaling up usually means switching equipment and re-optimizing settings. In this webinar, we will introduce a platform, Sunny Suite, that can reduce the time spent on these LNP formulations. ■ Date and Time: February 26 (Monday) 14:00~ ■ Speaker: Yuji Senoo, Field Application Scientist, Unchained Labs, Inc. ■ Register here: https://unchainedlabs.zoom.us/webinar/register/3217065146675/WN_U1o3xQoZRAKHN-A-7b1yqg

• Other protein analysis

It enables the monitoring of potency and purity throughout the entire workflow of lentivirus research and development, accelerating gene therapy development.

"Leprechaun" is a system that analyzes whether lentivirus particles are of the correct size and structure, and can measure viral titer. It allows for the determination of the titer of lentivirus present in a sample without being misled by confusing noise (such as incomplete viruses or contamination). Not only can it measure information that was previously only obtainable separately through conventional methods like ELISA, qPCR, and transduction assays, but it also enables structural analysis that those methods could not provide, all on a single platform. Capabilities: ■ Lentivirus titer ■ Lentivirus structure ■ Exosome concentration ■ Analysis of contamination (impurities such as extracellular vesicles) Features: ■ No sample purification required ■ Physical structural analysis possible ■ Distinction between virus integrity and impurities ■ Up to 16 samples can be measured at once *For more details, please refer to the PDF document or feel free to contact us.

• Other measurement and measuring equipment

[Lecture Topics] 1. Trends in Policies for Decarbonization of Housing and Buildings Tetsuya Hirayama, Deputy Director, Housing Bureau, Ministry of Land, Infrastructure, Transport and Tourism (in charge of architectural planning) 2. Construction Circular Economy - Expanding Horizontal Recycling for Achieving Sustainable Construction Takahiro Moritomi, Analyst, Social Infrastructure Team, Next Generation Infrastructure and Services Office, Industry Research Department, Mizuho Bank, Ltd. 3. Beyond "Scrap and Build" Aiming for the Realization of "Circular Design Build®" Shoichi Fukui, Senior Chief Expert, Sustainability Promotion Department, Management Planning Office, Takenaka Corporation

[Instructor] Attorney Kurato Suzuki, Irokawa Law Office [Key Lecture Content] Due to the amendments to the Comprehensive Promotion Law for Labor Policies, starting from October 1, 2026, employers will be required to take necessary measures in employment management regarding customer harassment (Kasu Hara) and sexual harassment against job seekers (Job Hunting Sexual Harassment). In line with this, companies will need to prepare for practical implementation before the enforcement date, based on the guidelines published by the Ministry of Health, Labour and Welfare. This includes developing internal regulations, establishing consultation and response systems, raising awareness within the company, and determining judgment and response methods on-site. This seminar will organize the setting of job hunting rules related to job hunting sexual harassment, internal awareness, and key points for regulatory development. It will also explain the distinction between legitimate complaints and customer harassment, judgment, documentation, and response on-site, the establishment of a company-wide system, regulatory development considering dispute risks, and points that are easily overlooked. The Human Resources, Labor, Legal, and Compliance departments will systematically organize the response matters that need to be confirmed in preparation for the enforcement on October 1, 2026, from the perspectives of guideline compliance and on-site operations. [Lecture Items] 1. Job Hunting Sexual Harassment 2. Customer Harassment 3. Q&A

[Speaker] Mr. Itsuki Wakayama, Project General Manager, Technology Promotion Unit, Low Carbon Solutions Division, INPEX Corporation [Key Lecture Content] The greatest advantage of synthetic methane production through CO2 methanation technology is that it enables decarbonization without significant additions or modifications to all existing natural gas and city gas infrastructure. At INPEX, after two NEDO commissioned projects, we have been conducting the development of practical application technology with a capacity of 400 Nm3-CO2/h, one of the largest in the world, as a subsidized project by NEDO since the fiscal year 2021. By the fiscal year 2025, we aim to achieve the injection of synthetic methane produced during the demonstration operation of the test facility. This presentation will provide detailed information on the results of the NEDO project for the fiscal year 2025, including the current status of the latest test facilities. [Presentation Items] 1. INPEX's efforts towards net zero by 2050 2. Policy trends related to CO2 methanation 3. Challenges of CO2 methanation 4. Results of the NEDO practical application technology development project with a capacity of 400 Nm3-CO2/h for the fiscal year 2025 5. Future commercialization prospects and challenges 6. Q&A / Business card exchange

[Speaker] Mr. Satoru Shimizu, President and CEO of Okunote Inc. [Key Lecture Content] Generative AI is not a "magic wand," but a "mirror" that reflects the questions of the user. In this lecture, based on my book "The 'Super' Planning Techniques Practiced by Competition Disruptors: Seven Creative Steps to Lead Winning Strategies with the 'Art of Questioning'," I will explain how to overcome the challenges of proposals being rejected, not moving forward within the company, and not being executed on-site through interactions with AI. I will introduce the entire process of planning, linking it with AI utilization, from question design to hypothesis destruction, structuring materials from the decision-maker's perspective, forming internal consensus, managing execution, and turning reflections into assets. In the latter part of the workshop (exclusive to on-site participants), you will actually formulate questions and refine your dialogue with AI, taking home usable "art of questioning" techniques for tomorrow. [Lecture Items] 1. Orientation: AI is a "mirror," not a "magic wand." 2. Enhancing the precision of planning through "question design" and "hypothesis destruction." 3. Structuring materials from the decision-maker's perspective to create "acceptable" proposals. 4. Forming consensus that transcends internal barriers. 5. Mechanisms that prevent execution from stopping and turning experiences into assets through reflection. 6. Habitualizing AI as a "partner" and the roles humans will take on in the AI era.

【Exhibition Overview】 A collection of products related to data centers, which are at the core of AI infrastructure, gathered in one place.